Quality of Life and Pulmonary Function after Lung Cancer Treatment: Systematic Review
Main Article Content
Abstract
Introduction: Lung cancer is the leading cause of cancer-related death worldwide. Its treatment has a significant impact on the physical and psychological well-being of patients, resulting in a reduction in health-related quality of life (HRQoL) and pulmonary function.
Objective: To provide a detailed assessment of the available literature on the impact of lung cancer treatment on the quality of life and functioning of patients.
Methods: A systematic review was conducted using advanced searches in the databases The Cochrane Library Plus, PubMed, and Science Direct. The selected publications were thoroughly analyzed, and the PRISMA scale (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) was used to display the selection process.
Results: A total of 51 articles were identified. Studies involving cancers other than lung cancer, or those that did not include questionnaires, spirometry tests, or the effects of physical exercise on patient outcomes, were subsequently excluded. After a full-text review, 11 articles met the previously defined criteria.
This literature review reveals that, in most of the studies examined, the quality of life of lung cancer patients tends to decline after treatment, reflecting the physical, emotional, and social challenges they face throughout the process.
Regarding lung function, the reviewed studies show that it deteriorates following treatment, resulting in a reduction in the patients’ respiratory capacity.
Conclusion: Although the results provide evidence of the impact of lung cancer and its treatment on various aspects of life, further research with larger sample sizes is necessary to validate these findings.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Suazo-Zepeda E, Vinke PC, Heuvelmans MA, Sidorenkov G, Hiltermann TJN, de Bock GH. Quality of life after treatment with immune checkpoint inhibitors for lung cancer; the impact of age. Lung Cancer. 2023;176:89-97. doi:10.1016/j.lungcan.2022.12.017
II. Oliveira PI, Pereira CAC, Belasco AGS, Bettencourt ARC. Comparison of the quality of life of lung cancer patients before and after chemotherapy treatment. Rev. Latino-Am. Enfermagem 21 (3). Jun 2013. doi.org:10.1590/S0104-11692013000300019
III. Cavalheri V, Granger CL. Exercise training as part of lung cancer therapy. Respirology. 2020;25 Suppl 2:80-87. doi:10.1111/resp.13869
IV. Avancini A, Sartori G, Gkountakos A, et al. Physical Activity and Exercise in Lung Cancer Care: Will Promises Be Fulfilled?. Oncologist. 2020;25(3):e555-e569. doi:10.1634/theoncologist.2019-0463
V. Duman E, Yildirim M, Kaya V, et al. Effects of Definitive Chemoradiotherapy on Respiratory Function Tests and Quality of Life Scores During Treatment of Lung Cancer. Asian Pac J Cancer Prev. 2015;16(15):6779-6782. doi:10.7314/apjcp.2015.16.15.6779
VI. Cukic V. Reduction of pulmonary function after surgical lung resections of different volume. Med Arch.2014;68(4):231-235. doi:10.5455/medarh.2014.68.231-235
VII. Poghosyan H, Sheldon LK, Leveille SG, Cooley ME. Health-related quality of life after surgical treatment in patients with non-small cell lung cancer: a systematic review. Lung Cancer. 2013;81(1):11-26. doi:10.1016/j.lungcan.2013.03.013
VIII. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR. How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res. 2003;12(2):157-166. doi:10.1023/a:1022232624891
IX. Leach HJ, Devonish JA, Bebb DG, Krenz KA, Culos-Reed SN. Exercise preferences, levels and quality of life in lung cancer survivors. Support Care Cancer. 2015;23(11):3239-3247. doi:10.1007/s00520-015-2717-6
X. Takemura N, Cheung DST, Fong DYT, et al. Effectiveness of Aerobic Exercise and Tai Chi Interventions on Sleep Quality in Patients With Advanced Lung Cancer: A Randomized Clinical Trial. JAMA Oncol. 2024;10(2):176-184. doi:10.1001/jamaoncol.2023.5248
XI. Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer. 2022;163:42-50. doi:10.1016/j.lungcan.2021.11.012
XII. Yokoba M, Ichikawa T, Harada S, Naito M, Sato Y, Katagiri M. Postoperative pulmonary function changes according to the resected lobe: a 1-year follow-up study of lobectomized patients. J Thorac Dis. 2018;10(12):6891-6902.
doi:10.21037/jtd.2018.11.108
XIII. Takemoto S, Shibamoto Y, Hashizume C, et al. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer. J Radiat Res. 2021;62(2):338-345.
doi:10.1093/jrr/rraa131
XIV. Okamoto K, Hayashi K, Kaku R, Kawaguchi Y, Oshio Y, Hanaoka J. Airway inflammation and lung function recovery after lobectomy in patients with primary lung cancer. Gen Thorac Cardiovasc Surg. 2021;69(2):297-302. doi:10.1007/s11748-020-01464-6
XV. Win T, Groves AM, Ritchie AJ, Wells FC, Cafferty F, Laroche CM. The effect of lung resection on pulmonary function and exercise capacity in lung cancer patients. Respir Care. 2007;52(6):720-726.
XVI. Marinovic DA, Hunter RL. Examining the interrelationships between mindfulness-based interventions, depression, inflammation, and cancer survival. CA Cancer J Clin. 2022;72(5):490-502. doi:10.3322/caac.21733